4-Quinolinecarboxylic acid
CAS 486-74-8 · C10H7NO2 · MW 173.17 g/mol
正在加载分子...
科学文献
Related literature
16 articles · 3 open access · Sources: PubMed, OpenAlex, Semantic Scholar
📈 Publication timeline (16 articles)
Bar height = number of articles per year. Hover dla szczegółów.
et al. (1985)
et al. (2006)
et al. (2024)
Yu. A. Zhuravleva, A. V. Zimichev, M. Zemtsova et al. (2008)
H. Hayashi, Y. Miwa, S. Ichikawa et al. (1993) · Journal of Medicinal Chemistry
AI Summary
Compound 6f dose-dependently attenuated both the incidence and frequency of emetic episodes induced by cisplatin in the dog more potently than ondansetron and is now under further investigation as a drug for treating gastrointestinal disorder.
Compound 6f dose-dependently attenuated both the incidence and frequency of emetic episodes induced by cisplatin in the dog more potently than ondansetron and is now under further investigation as a drug for treating gastrointestinal disorder.
(2008) · Organic Syntheses
N. Hakobyan, A. Grigoryan, R. Madoyan et al. (2026) · Russian journal of bioorganic chemistry
AI Summary
The Atophan scaffold is a valuable basis for designing multitarget bioactive molecules and promising lead compounds for further development as antidepressants, antibacterial, antifungal, and anticancer agents are confirmed.
The Atophan scaffold is a valuable basis for designing multitarget bioactive molecules and promising lead compounds for further development as antidepressants, antibacterial, antifungal, and anticancer agents are confirmed.
$ PaywallDOI ↗
M. Cygler, C. P. Huber (1985)
SHIZUO KADOYA, SENKICHI NAGASAKI (1979) · YAKUGAKU ZASSHI
A. Musumeci (1981) · Inorganica Chimica Acta
A. Palomer, L. Anglada (2010)
$ Paywall
アロマタリオ ヴァレンティーナ, トゥルチェッタ ステファノ, マッサルド ピエトロ (2004)
$ Paywall
J. Liu, Y. Wei, H. Guo (2001) · Yao xue xue bao = Acta pharmaceutica Sinica
AI Summary
In vitro antibacterial activities of the compounds (8-15) against Staphylococcus aureus, Escherichia coli-26 and Pseudomonas aeruginosa-17 were lower than control of ciprofloxacin.
In vitro antibacterial activities of the compounds (8-15) against Staphylococcus aureus, Escherichia coli-26 and Pseudomonas aeruginosa-17 were lower than control of ciprofloxacin.
$ PaywallPubMed ↗
J. Qi, Hui-yuan Guo, Ming-liang Liu et al. (2004) · Yao xue xue bao = Acta pharmaceutica Sinica
AI Summary
Compounds (23, 24 and 26) showed excellent antibacterial activity in vitro and in vivo and should be worth further investigation.
Compounds (23, 24 and 26) showed excellent antibacterial activity in vitro and in vivo and should be worth further investigation.
L. Kononov, G. Veinberg, É. Liepin'sh et al. (1988)
K.P. Madauss, S.P. Williams, D.N. Deaton (2010) · Worldwide Protein Data Bank
$ PaywallDOI ↗
Dane z PubMed (NIH NLM), OpenAlex (CC0), Semantic Scholar (AI2). AI Summary wygenerowane przez Semantic Scholar TLDR. Artykuły z ikoną 
wymagają płatnego dostępu.